Alnylam Pharmaceuticals
ALNY
#651
Rank
ยฃ28.83 B
Marketcap
ยฃ216.00
Share price
0.68%
Change (1 day)
7.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company